Related Experiment Video

Updated: Jun 18, 2026

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells
06:55

Measurement of Natural Killer Cell-Mediated Cytotoxicity and Migration in the Context of Hepatic Tumor Cells

Published on: February 22, 2020

Dysfunction of natural killer cells in patients with transitional cell carcinoma

Chang-Te Lin1, Min-Tsung Yu, Chin Li

  • 1Department of Urology, Chia-Yi Christian Hospital, National Chung Cheng University, Taiwan.

Cancer Letters
|November 26, 2009
PubMed

Insights

Elevated transforming growth factor-beta1 (TGF-beta1) in superficial bladder cancer patients correlates with reduced natural killer (NK) cell function. This suggests innate immune alterations may contribute to transitional cell carcinoma (TCC) development.

Area of Science:

  • Immunology
  • Oncology
  • Urothelial Carcinomas

Background:

  • Transforming growth factor-beta1 (TGF-beta1) is implicated in bladder tumor progression.
  • Natural killer (NK) cells play a crucial role in innate immunity against tumors.

Purpose of the Study:

  • To investigate the relationship between TGF-beta1 levels and NK cell function in superficial transitional cell carcinoma (TCC).

Main Methods:

  • Quantified NK cell number and cytotoxic function in TCC patients.
  • Measured plasma TGF-beta1 concentrations.
  • Assessed NK cell function in vitro with TGF-beta1 exposure.

Main Results:

  • Superficial TCC patients exhibited decreased NK cell number and cytotoxicity.
  • Elevated plasma TGF-beta1 concentrations were observed in these patients.
  • In vitro, TGF-beta1 impaired NK cell cytotoxic activity.

Conclusions:

  • Elevated serum TGF-beta1 is associated with reduced NK cell cytotoxicity in superficial TCC.
  • Altered innate immunity, specifically NK cell function, may be linked to TCC incidence.

More Related Videos

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity06:08

A Flow Cytometry-Based Cytotoxicity Assay for the Assessment of Human NK Cell Activity

Published on: August 9, 2017

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Cells of the Innate Immune Response01:28

Cells of the Innate Immune Response

The innate immune response is an immediate and non-specific response against pathogens, acting swiftly to prevent the spread of infections. The primary cells involved in this response are phagocytes and natural killer (NK) cells.
Phagocytes
Phagocytes police the peripheral tissues by removing cellular debris and responding to the invasion of foreign substances or pathogens. Many phagocytes attack and remove microorganisms even before lymphocytes detect them. The human body has two general...
Immune Surveillance by NK Cells and Phagocytes01:25

Immune Surveillance by NK Cells and Phagocytes

Immune surveillance is an integral part of the innate immune system, involving the continuous monitoring of peripheral tissues to detect and respond to pathogens, infected cells, or cancerous cells. This surveillance is conducted primarily by natural killer (NK) cells and phagocytes, which employ distinct but complementary mechanisms to identify and eliminate threats.
Natural Killer Cells: The Fast Responders
NK cells are large granular lymphocytes found in the blood and lymphatic system. These...
Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.